Antibiotic Decisions in Neonates at Risk of Early-Onset Sepsis

EAPS — Antibiotic Decisions in Neonates — Body Content + Sidebar
On-demand course

Antibiotic Decisions in Neonates at Risk of Early-Onset Sepsis

When should antibiotics be stopped, continued intravenously or switched to oral treatment in neonates with suspected early-onset sepsis?

This interactive activity explores current guidance and emerging evidence on neonatal antibiotic management. Through expert insights, clinical scenarios and interactive questions, consider the risks and benefits of different treatment approaches and the evidence supporting IV-to-oral antibiotic switch in carefully selected neonates.

Learning outcomes

By completing this session, you should be able to:

  • 01Explain the key factors that inform reassessment of ongoing antibiotic treatment in suspected early-onset neonatal sepsis.
  • 02Discuss the evidence supporting oral antibiotic treatment and early IV-to-oral switch in selected neonates.
  • 03Distinguish between clinical circumstances that may favour stopping, switching or continuing antibiotic treatment.
EAPS — Antibiotic Decisions in Neonates — Faculty

Faculty

Course expert
Dr. Justin Penner
Paediatric Infectious Disease Consultant · Lead, Perinatal Infection Service · Imperial College Healthcare NHS Trust · London, UK

Dr. Penner trained in paediatrics in Winnipeg, Canada, followed by paediatric infectious diseases fellowships at Great Ormond Street Hospital and St Mary's Hospital in London. He holds an MSc in international health from the London School of Hygiene and Tropical Medicine and a diploma in tropical medicine. As an honorary senior lecturer at Imperial College London, his research focuses on paediatric HIV, congenital CMV and syphilis, perinatal transmission of HTLV-1 and neonatal bacterial infections.

Start learning with EAPS Education Start the course →